Original paper

Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity

Volume: 269, Pages: 364 - 373
Published: Jan 1, 2018
Abstract
Strategies that enhance the host antitumor immune response promise to revolutionize cancer therapy. Optimally mobilizing the immune system will likely require a multi-pronged approach to overcome the resistance developed by tumors to therapy. Recently, it has become recognized that doxorubicin can contribute to re-establishing host antitumor immunity through the generation of immunogenic cell death. However, the potential for delivery strategies...
Paper Details
Title
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
Published Date
Jan 1, 2018
Volume
269
Pages
364 - 373
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.